Innoviz Technologies Ltd. (INVZ) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2025, filed Mar 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the INVZ SEC filings page.
Innoviz Technologies Ltd. (INVZ) reported $55.1M in revenue for fiscal year 2025, up 127.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue scale and better unit economics finally produced positive gross margin, but engineering-led spending still keeps operations loss-making.
FY2025’s gross margin reached23.4% while operating margin remained-123.0% , showing that positive unit economics have not yet absorbed the development cost structure. R&D slightly exceeded revenue, so the central transition is from making products at a gross loss to funding a still-heavy engineering base; that is a different problem from weak sales alone.
From FY2024 to FY2025, operating cash flow and free cash flow both became less negative, but FY2025 operating cash flow was
External funding remains part of the financing model: debt-to-equity rose between FY2024 and FY2025, while the share count increased and financing cash flow remained positive. The current ratio was 2.9x, and reported liquidity equaled 4.5 months of annual operating outflow, so near-term resources coexist with ongoing reliance on capital markets.
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Innoviz Technologies Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Innoviz Technologies Ltd. held $18.1M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $47.9M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Innoviz Technologies Ltd. scores 17/100 among other emerging companies.
Innoviz Technologies Ltd. had 214M shares outstanding at the end of fiscal year 2025, against 169M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Innoviz Technologies Ltd. scores 43/100 among other emerging companies.
Innoviz Technologies Ltd. spent $56.5M on research and development in fiscal year 2025, which was 46.0% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Innoviz Technologies Ltd. scores 75/100 among other emerging companies.
Innoviz Technologies Ltd. reported revenue of $55.1M in fiscal year 2025, against $24.3M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Innoviz Technologies Ltd. scores 82/100 among other emerging companies.
Innoviz Technologies Ltd.'s operations used $47.9M of cash in fiscal year 2025, against $77.0M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Innoviz Technologies Ltd. scores 71/100 among other emerging companies.
Innoviz Technologies Ltd.'s cash, cash equivalents and investments came to $18.1M at the end of fiscal year 2025, against $60.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Innoviz Technologies Ltd. scores 33/100 among other emerging companies.
Innoviz Technologies Ltd. scores -7.72, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($106.6M) relative to total liabilities ($60.7M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Innoviz Technologies Ltd. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Innoviz Technologies Ltd. reported a net loss of $67.8M while operations used $47.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Innoviz Technologies Ltd. earned -$0.10 per diluted share (EPS) in Q4 2025. This represents an increase of 9.1% from the same quarter a year earlier.
Not reported for Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Cash & Balance Sheet
Innoviz Technologies Ltd. recorded an outflow of $10.2M in free cash flow in Q4 2025, representing a cash shortfall after capex. This represents an increase of 46.6% from the same quarter a year earlier. Against the prior quarter it is up 27.4%.
Innoviz Technologies Ltd. held $8.6M in cash as of Q4 2025; long-term debt is not reported for that period.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
Innoviz Technologies Ltd. invested $1.0M in capex in Q4 2025, funding long-term assets and infrastructure. This represents a decrease of 12.7% from the same quarter a year earlier. Against the prior quarter it is up 263.6%.
Not reported for Q4 2025.
Not reported for Q4 2025.
INVZ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, Diluted Shares (Avg).
INVZ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'256-K | Q2'256-K | Q4'2410-K | Q3'246-K | Q2'2410-Q | Q4'2310-K | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $138.5M+4.8% | $151.1M | $151.1M-9.4% | $132.0M-39.8% | N/A | $166.8M-16.1% | $219.2M-14.2% | $198.8M-35.7% |
| Current Assets | $90.2M+9.2% | $102.2M | $100.9M-11.8% | $82.6M-48.5% | N/A | $114.4M-12.7% | $160.5M-14.4% | $131.1M-43.1% |
| Cash & Equivalents | $8.6M-65.9% | $7.9M-71.8% | $13.5M-43.6% | $25.4M-3.5% | $27.9M | $24.0M-30.1% | $26.3M-52.8% | $34.3M-31.7% |
| Short-Term Investments | $9.5M-20.8% | $9.4M | $9.3M-39.3% | $12.0M-10.3% | $0 | $15.3M-38.0% | $13.3M-68.0% | $24.6M+12.6% |
| Inventory | $3.3M+75.5% | $3.0M | $3.2M+82.6% | $1.9M+2.0% | N/A | $1.8M-61.8% | $1.9M-55.9% | $4.6M-1.4% |
| Accounts Receivable | $10.0M+65.1% | $19.8M | $11.6M+114.5% | $6.0M-18.3% | N/A | $5.4M+127.5% | $7.4M+319.7% | $2.4M+121.6% |
| Long-Term Investments | $0 | $0 | $0-100.0% | $0-100.0% | $0 | $1.2M-84.3% | $4.8M-38.6% | $7.8M-71.3% |
| Total Liabilities | $60.7M+14.3% | $61.4M | $58.0M+7.2% | $53.1M-19.4% | N/A | $54.1M-12.9% | $65.9M+4.0% | $62.1M+4.9% |
| Current Liabilities | $31.4M+13.2% | $32.1M | $28.3M+1.1% | $27.8M-25.4% | N/A | $28.0M-16.1% | $37.2M+14.8% | $33.4M+20.0% |
| Non-Current Liabilities | $29.3M+15.6% | $29.3M | $29.7M+13.7% | $25.4M-11.7% | N/A | $26.1M-9.1% | $28.7M-7.3% | $28.7M-8.5% |
| Total Equity | $77.7M-1.5% | $89.7M-3.2% | $93.1M-17.4% | $78.9M-48.5% | $92.6M | $112.7M-17.5% | $153.3M-20.2% | $136.7M-45.3% |
| Retained Earnings | -$797.8M-9.3% | -$776.6M | -$761.2M-10.9% | -$730.0M-14.9% | N/A | -$686.6M-18.8% | -$635.3M-24.1% | -$577.8M-30.3% |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
INVZ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'256-K | Q2'256-K | Q4'2410-K | Q3'246-K | Q2'2410-Q | Q4'2310-K | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$9.1M+48.8% | -$13.7M+16.7% | N/A | -$17.8M | -$16.5M | N/A | N/A | N/A |
| Depreciation & Amortization | $1.8M+12.9% | $1.4M-36.9% | N/A | $1.6M | $2.2M | N/A | N/A | N/A |
| Capital Expenditures | $1.0M-12.7% | $286K-76.0% | N/A | $1.2M | $1.2M | N/A | N/A | N/A |
| Free Cash Flow | -$10.2M+46.6% | -$14.0M+20.7% | N/A | -$19.0M | -$17.7M | N/A | N/A | N/A |
| Investing Cash Flow | $4.8M-68.4% | -$769K-103.8% | N/A | $15.1M | $20.1M | N/A | N/A | N/A |
| Financing Cash Flow | $5.0M+9076.4% | $8.9M+15182.8% | N/A | $55K | $58K | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.
INVZ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Innoviz Technologies Ltd. INVZ | FY2025 | $55.1M | -$67.8M | N/A | $106.6M | 54/100 |
| SES AI Corporation SES | FY2025 | $21.0M | -$73.0M | N/A | $303.1M | 74/100 |
| Holley Inc. HLLY | FY2025 | $613.5M | $19.2M | 3.1% | $288.5M | 47/100 |
| Miller Industries, Inc. MLR | FY2025 | $790.3M | $23.0M | 2.9% | $603.8M | 36/100 |
| Motorcar Parts of America, Inc. MPAA | FY2026 | $789.8M | $12.0M | 1.5% | $195.8M | 47/100 |
| Solid Power, Inc. SLDP | FY2025 | $21.7M | -$93.4M | N/A | $538.5M | 64/100 |
Where Innoviz Technologies Ltd. Ranks
Frequently Asked Questions
What is Innoviz Technologies Ltd.'s annual revenue?
Innoviz Technologies Ltd. (INVZ) reported $55.1M in total revenue for fiscal year 2025. This represents a 127.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Innoviz Technologies Ltd.'s revenue growing?
Innoviz Technologies Ltd. (INVZ) revenue grew by 127.0% year-over-year, from $24.3M to $55.1M in fiscal year 2025.
Is Innoviz Technologies Ltd. profitable?
No, Innoviz Technologies Ltd. (INVZ) reported a net income of -$67.8M in fiscal year 2025.
What is Innoviz Technologies Ltd.'s EBITDA?
Innoviz Technologies Ltd. (INVZ) had EBITDA of -$61.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Innoviz Technologies Ltd.'s gross margin?
Innoviz Technologies Ltd. (INVZ) had a gross margin of 23.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Innoviz Technologies Ltd.'s return on equity (ROE)?
Innoviz Technologies Ltd. (INVZ) has a return on equity of -87.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Innoviz Technologies Ltd.'s free cash flow?
Innoviz Technologies Ltd. (INVZ) recorded an outflow of $52.2M in free cash flow during fiscal year 2025. This represents a 35.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Innoviz Technologies Ltd.'s operating cash flow?
Innoviz Technologies Ltd. (INVZ) recorded an outflow of $47.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Innoviz Technologies Ltd.'s total assets?
Innoviz Technologies Ltd. (INVZ) had $138.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Innoviz Technologies Ltd.'s capital expenditures?
Innoviz Technologies Ltd. (INVZ) invested $4.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Innoviz Technologies Ltd. spend on research and development?
Innoviz Technologies Ltd. (INVZ) invested $56.5M in research and development during fiscal year 2025.
What is Innoviz Technologies Ltd.'s current ratio?
Innoviz Technologies Ltd. (INVZ) had a current ratio of 2.87 as of fiscal year 2025, which is generally considered healthy.
What is Innoviz Technologies Ltd.'s debt-to-equity ratio?
Innoviz Technologies Ltd. (INVZ) had a debt-to-equity ratio of 0.78 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Innoviz Technologies Ltd.'s return on assets (ROA)?
Innoviz Technologies Ltd. (INVZ) had a return on assets of -49.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Innoviz Technologies Ltd.'s P/E ratio?
Innoviz Technologies Ltd. (INVZ) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $106.6M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Innoviz Technologies Ltd.'s price-to-sales ratio?
Innoviz Technologies Ltd. (INVZ) trades at 1.9x sales, its market capitalization divided by revenue of $55.1M revenue, FY2025. The market capitalization is $106.6M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Innoviz Technologies Ltd.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Innoviz Technologies Ltd. (INVZ) held $18.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $47.9M over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Innoviz Technologies Ltd.'s Altman Z-Score?
Innoviz Technologies Ltd. (INVZ) has an Altman Z-Score of -7.72, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Innoviz Technologies Ltd.'s Piotroski F-Score?
Innoviz Technologies Ltd. (INVZ) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Innoviz Technologies Ltd.'s earnings high quality?
Innoviz Technologies Ltd. (INVZ) reported a net loss of $67.8M while operations used $47.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Innoviz Technologies Ltd.?
Innoviz Technologies Ltd. (INVZ) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.